Dey News

PITTSBURGH, May 29, 2012 /PRNewswire/ -- Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg.

Mylan Inc. today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve the parties' patent litigation relating to Sunovion's Brovana product.

Craig Morgan, Phil Vassar, Diamond Rio, Due West, Joe Grushecky and Scott Blasey of The Clarks-a Peters Township resident-will be featured in the Mylan Classic's 2012 concert series.

PITTSBURGH, May 24, 2012 /PRNewswire/ -- Mylan Inc. today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve the parties' patent litigation relating to Sunovion's Brovana product.

Craig Morgan, Phil Vassar, Diamond Rio, Due West, Joe Grushecky and Scott Blasey of The Clarks will be featured in the Mylan Classic's 2012 concert series.

PITTSBURGH, May 23, 2012 /PRNewswire/ -- Mylan Inc. today reported that Moody's Investors Service has upgraded the company's credit ratings, including the "Corporate Family Rating," to Ba1 from Ba2.

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nevirapine Tablets USP, 200 mg.

PITTSBURGH, May 17, 2012 /PRNewswire/ -- Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc.

Mylan Inc. raised its 2012 earnings forecast on Thursday, just a few weeks after the generic drugmaker reported a 24 percent increase in its first-quarter net income.

Pittsburgh, PA, LYON, France /PRNewswire/ -- Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland.

Drug manufacturer Mylan is set to release Atorvastatin Calcium Tablets in Belgium, France, Ireland, the Netherlands, and the United Kingdom.

Boeing Co. : Sterne Agee expects Boeing's Investor Day to be positive for the stock, as the firm thinks the company is making significant progress on its new programs.

PITTSBURGH and LYON, France, May 11, 2012 /PRNewswire/ -- Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland.

Mylan said it expected between $2.45 and $2.55 in diluted earnings per share in 2012, up from its previous guidance of $2.30 to $2.50 a share.

Mylan Inc. raised its 2012 earnings forecast on Thursday, just a few weeks after the generic drugmaker reported a 24 percent increase in its first-quarter net income.

Motorola, Inc. : After Motorola Solutions reported higher than expected Q1 EPS, Argus thinks that the shares are poised to advance because its earnings are growing faster than its stock price.

Some quick facts as to why Raptor Pharmaceuticals could be on the verge of attracting increased attention from biotech investors given the upcoming catalysts, strong pipeline, cash position and impressive leadership team.

Mylan Inc. to Partner with United Nations and Clinton Health Access Initiative to Fight Diarrhea Fatalities in Children in India /PRNewswire/ -- Mylan Laboratories Limited, the Indian subsidiary of Mylan Inc.

PITTSBURGH, April 30, 2012 /PRNewswire/ -- Mylan Inc. today announced that it has entered into a settlement agreement with Teva that will resolve pending patent litigation related to Nuvigil .